Back to Tudor Investment Corp. Tudor Investment Corp.

TVTXTVTX

Showing 8 of 22 quarters

Position history for Tudor Investment Corp.Tudor Investment Corp.'s holdings in Travere Therapeutics, Inc.

No. Tudor Investment exited its TVTX (Travere Therapeutics) position in Q3 2026. Its Q2 2026 13F listed 5,955 shares worth $338,304. Tudor Investment first reported TVTX in Q2 2021 and held it in 19 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$752,770

Total Shares Change

-43,213

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Exited
0
-100.0%
$00.0%$58.88
0
2026-Q2
Decreased
5,955
-82.2%
$338,3040.0%$56.81
0
2026-Q1
Decreased
33,361
-46.4%
$991,1550.0%$29.71
0
2025-Q4
Decreased
62,186
-35.0%
$2.4M0.0%$38.21
0
2025-Q3
Decreased
95,747
-52.5%
$2.3M0.0%$23.90
0
2025-Q2
Increased
201,508
+23.3%
$3M0.0%$14.80
32
2025-Q1
Increased
163,378
+278.1%
$2.9M0.0%$17.92
42
2024-Q4
Increased
43,213
+13.3%
$752,7700.0%$17.42
28

Optional analytics helps us improve. How it’s used